SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Debt Instrument, Face Amount
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Debt Instrument, Face Amount of $2.00 million as of 2025-02-27, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2025-08-13
- 2025-02-27: Debt Instrument, Face Amount $2.00M.
- 2023-03-31: Debt Instrument, Face Amount $162.56K.
- 2022-09-30: Debt Instrument, Face Amount $500.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2025-02-27 | $2.00M 10-Q · filed 2025-08-13 |
| 2023-03-31 | $162.56K 10-Q · filed 2023-05-25 |
| 2022-09-30 | $500.00K 10-K/A · filed 2024-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |